MSTN and liver disorder: Although this may seem initially contradictory to reported clinical reports of increased circulating myostatin levels in liver disease patients who present with muscle atrophy [40,41], our data suggest that muscle may not be the sole source of increased circulating Gdf8 observed in these patients.